Home › Funds › Barden Capital Management, Inc. › ELV

Barden Capital Management, Inc. position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

Barden Capital Management, Inc. reported holding 1,610 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$626K, representing 0.57% of its reported portfolio and ranking #48 among its reported holdings. Barden Capital Management, Inc. has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.61K sh
Reported value held$626.00K
Portfolio Weight0.57%
First reportedQ3 2023
Last changeHold
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How Barden Capital Management, Inc.'s ELV position evolved

Barden Capital Management, Inc. first disclosed a stake in ELV in Q3 2023 at 4,244 shares (US$1.8M). The position peaked in Q4 2023 at 9,902 shares, worth US$4.4M. Across 13 filings, Barden Capital Management, Inc. increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,610 shares valued at US$626K. Notable position changes include a 133% increase in Q4 2023 (shares rose 10% over the following quarter), a 58% trim in Q1 2024 (shares rose 5% over the following quarter), a 50% trim in Q4 2024 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.24K $1.85M New
Q4 2023 9.90K $4.36M Add
Q1 2024 4.13K $2.14M Reduce
Q2 2024 4.15K $2.25M Add
Q3 2024 4.25K $2.21M Add
Q4 2024 2.14K $787.97K Reduce
Q1 2025 2.23K $968.66K Add
Q2 2025 2.18K $847.93K Reduce
Q3 2025 1.96K $632.02K Reduce
Q4 2025 1.99K $697.60K Add
Q1 2026 2.22K $648.73K Add
Q2 2026 1.61K $622.25K Reduce
Q3 2026 1.61K $626.00K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has Barden Capital Management, Inc. held ELV?

Barden Capital Management, Inc. has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Barden Capital Management, Inc.'s current position in ELV?

As of Q3 2026, Barden Capital Management, Inc. holds 1.61K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $626.00K, representing 0.57% of its reported portfolio and ranking #48.

Has Barden Capital Management, Inc. been buying or selling ELV?

In the latest 13F filing (Q3 2026), Barden Capital Management, Inc. held unchanged its position in ELV. The position peaked in Q4 2023 at 9.90K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.